Cairo- Mubasher: The Egyptian International Pharmaceutical Industries Company (EIPICO) posted a year-on-year increase in its unconsolidated profits during the first half of 2019, based on the initial unaudited statements of the company.
EIPICO logged EGP 371.2 million in H1-19, compared to EGP 368.5 million in H1-18, including minority shareholders’ rights, EIPICO disclosed to the Egyptian Exchange (EGX) on Wednesday.
Sales hiked to EGP 1.6 billion in H1-19 from EGP 1.3 billion in H1-18.
It is worth noting that during the first quarter of 2019, the company’s net profits surged to EGP 218.31 from EGP 183.97 million in Q1-18.
